Francisco David has filed 25 insider transactions across 1 company since February 2023.
Most recent transaction: a tax payment of 14687 shares of Organogenesis Holdings Inc. ($ORGO) on February 18, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | F | Class A Common Stock | 14687 | $3.84 | 731,312.0000 | 130,848,995 | 1.97% | 0.01% |
| Feb. 18, 2026 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | A | Class A Common Stock | 44040 | $0.00 | 745,999.0000 | 130,848,995 | 6.27% | 0.03% |
| Feb. 18, 2026 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | A | Stock Option (Right to Buy) | 111358 | $0.00 | 111,358.0000 | 130,848,995 | 9999.99% | 0.09% |
| Feb. 18, 2026 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | F | Class A Common Stock | 14541 | $3.84 | 731,020.0000 | 130,848,995 | 1.95% | 0.01% |
| Feb. 18, 2026 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | A | Class A Common Stock | 43602 | $0.00 | 745,561.0000 | 130,848,995 | 6.21% | 0.03% |
| Feb. 18, 2026 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | A | Class A Common Stock | 195312 | $0.00 | 701,959.0000 | 130,848,995 | 38.55% | 0.15% |
| Feb. 15, 2026 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | F | Class A Common Stock | 13369 | $3.73 | 520,416.0000 | 130,848,995 | 2.50% | 0.01% |
| Feb. 15, 2026 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | F | Class A Common Stock | 3898 | $3.73 | 555,197.0000 | 130,848,995 | 0.70% | 0.00% |
| Feb. 15, 2026 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | F | Class A Common Stock | 13769 | $3.73 | 506,647.0000 | 130,848,995 | 2.65% | 0.01% |
| Feb. 15, 2026 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | F | Class A Common Stock | 21412 | $3.73 | 533,785.0000 | 130,848,995 | 3.86% | 0.02% |
| Feb. 19, 2025 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | A | Class A Common Stock | 165156 | $0.00 | 559,095.0000 | 131,673,278 | 41.92% | 0.13% |
| Feb. 19, 2025 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | A | Stock Option (Right to Buy) | 170841 | $0.00 | 170,841.0000 | 131,673,278 | 9999.99% | 0.13% |
| Feb. 16, 2025 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | F | Class A Common Stock | 804 | $3.70 | 393,939.0000 | 131,673,278 | 0.20% | 0.00% |
| Feb. 15, 2025 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | F | Class A Common Stock | 2960 | $3.70 | 394,743.0000 | 131,673,278 | 0.74% | 0.00% |
| Feb. 15, 2025 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | F | Class A Common Stock | 11765 | $3.70 | 417,231.0000 | 131,673,278 | 2.74% | 0.01% |
| Feb. 15, 2025 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | F | Class A Common Stock | 19528 | $3.70 | 397,703.0000 | 131,673,278 | 4.68% | 0.01% |
| Feb. 21, 2024 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | A | Stock Option (Right to Buy) | 289915 | $0.00 | 289,915.0000 | 132,746,727 | 9999.99% | 0.22% |
| Feb. 21, 2024 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | A | Class A Common Stock | 160350 | $0.00 | 428,996.0000 | 132,746,727 | 59.69% | 0.12% |
| Feb. 15, 2024 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | F | Class A Common Stock | 18966 | $3.68 | 272,963.0000 | 132,746,727 | 6.50% | 0.01% |
| Feb. 16, 2024 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | F | Class A Common Stock | 804 | $3.48 | 268,646.0000 | 132,746,727 | 0.30% | 0.00% |
| Feb. 15, 2024 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | F | Class A Common Stock | 3513 | $3.68 | 269,450.0000 | 132,746,727 | 1.29% | 0.00% |
| Feb. 22, 2023 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | A | Stock Option (Right to Buy) | 287892 | $0.00 | 287,892.0000 | 132,383,152 | 9999.99% | 0.22% |
| Feb. 22, 2023 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | A | Class A Common Stock | 242508 | $0.00 | 291,929.0000 | 132,383,152 | 490.70% | 0.18% |
| Feb. 16, 2023 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | F | Class A Common Stock | 953 | $2.75 | 49,421.0000 | 132,383,152 | 1.89% | 0.00% |
| Feb. 15, 2023 | Organogenesis Holdings Inc. | $ORGO | Francisco David | Chief Financial Officer | F | Class A Common Stock | 3506 | $2.92 | 50,374.0000 | 132,383,152 | 6.51% | 0.00% |